Pinar Karaca Mandic
Cited by
Cited by
Interaction terms in nonlinear models
P Karaca‐Mandic, EC Norton, B Dowd
Health services research 47 (1pt1), 255-274, 2012
Varying pharmacy benefits with clinical status: the case of cholesterol-lowering therapy
DP Goldman, GF Joyce, P Karaca-Mandic
American Journal of Managed Care 12 (1), 21, 2006
The accident externality from driving
AS Edlin, P Karaca-Mandic
Journal of Political Economy 114 (5), 931-955, 2006
Going-private decisions and the Sarbanes-Oxley Act of 2002: A cross-country analysis
E Kamar, P Karaca-Mandic, E Talley
The Journal of Law, Economics, & Organization 25 (1), 107-133, 2009
Opioid prescribing by multiple providers in Medicare: retrospective observational study of insurance claims
AB Jena, D Goldman, L Weaver, P Karaca-Mandic
Bmj 348, 2014
Standard error correction in two‐stage estimation with nested samples
P Karaca‐Mandic, K Train
The Econometrics Journal 6 (2), 401-407, 2003
Out-of-pocket medication costs and use of medications and health care services among children with asthma
P Karaca-Mandic, AB Jena, GF Joyce, DP Goldman
Jama 307 (12), 1284-1291, 2012
Behavioral impact of graduated driver licensing on teenage driving risk and exposure
P Karaca-Mandic, G Ridgeway
Journal of health economics 29 (1), 48-61, 2010
Hospital prescribing of opioids to Medicare beneficiaries
AB Jena, D Goldman, P Karaca-Mandic
JAMA internal medicine 176 (7), 990-997, 2016
Cost sharing, family health care burden, and the use of specialty drugs for rheumatoid arthritis
P Karaca‐Mandic, GF Joyce, DP Goldman, M Laouri
Health services research 45 (5p1), 1227-1250, 2010
Less intense postacute care, better outcomes for enrollees in Medicare Advantage than those in fee-for-service
PJ Huckfeldt, JJ Escarce, B Rabideau, P Karaca-Mandic, N Sood
Health Affairs 36 (1), 91-100, 2017
Health and health risks among sexual minority women: An examination of 3 subgroups
JM Przedworski, DD McAlpine, P Karaca-Mandic, NA VanKim
American journal of public health 104 (6), 1045-1047, 2014
Lymphedema prevalence and treatment benefits in cancer: impact of a therapeutic intervention on health outcomes and costs
KM Brayton, AT Hirsch, JO Patricia, A Cheville, P Karaca-Mandic, ...
PLoS One 9 (12), e114597, 2014
Sarbanes-Oxley's effects on small firms: What is the evidence?
E Kamar, P Karaca-Mandic, EL Talley
USC CLEO research paper, 07-8, 2007
Assessment of COVID-19 hospitalizations by race/ethnicity in 12 states
P Karaca-Mandic, A Georgiou, S Sen
JAMA internal medicine 181 (1), 131-134, 2021
Predicting new diagnoses of HIV infection using internet search engine data
AB Jena, P Karaca-Mandic, L Weaver, SA Seabury
Clinical infectious diseases 56 (9), 1352-1353, 2013
The cutaneous, net clinical, and health economic benefits of advanced pneumatic compression devices in patients with lymphedema
P Karaca-Mandic, AT Hirsch, SG Rockson, SH Ridner
JAMA dermatology 151 (11), 1187-1193, 2015
Pharmacy benefit caps and the chronically ill
GF Joyce, DP Goldman, P Karaca-Mandic, Y Zheng
Health Affairs 26 (5), 1333-1344, 2007
Association of stay-at-home orders with COVID-19 hospitalizations in 4 states
S Sen, P Karaca-Mandic, A Georgiou
Jama 323 (24), 2522-2524, 2020
Is the medical loss ratio a good target measure for regulation in the individual market for health insurance?
P Karaca‐Mandic, JM Abraham, K Simon
Health economics 24 (1), 55-74, 2015
The system can't perform the operation now. Try again later.
Articles 1–20